Regular, low-dose, sustained-release morphine for persisting breathlessness in interstitial lung disease: a randomised, double-blind, placebo-controlled, crossover trial
Diana Ferreira, Magnus Ekström, Sabrina Bajwah, Belinda Fazekas, David C. Currow
Abstract
<h3>Tweetable abstract</h3> <b>In this trial of low-dose, sustained-release morphine for breathlessness in ILD there was no clear signal of improvement; morphine was associated with more harms. Predictors of response and factors influencing perception of benefit need to be identified.</b>https://bit.ly/45TM7Jf
Topics & Concepts
MorphineCrossover studyMedicinePlaceboDouble blindInterstitial lung diseaseAnesthesiaLungInternal medicineAlternative medicinePathologyRespiratory and Cough-Related ResearchChronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseases